Enovis Corp. (ENOV)
20.53
-4.06
(-16.51%)
USD |
NYSE |
Sep 01, 16:00
20.80
+0.27
(+1.32%)
After-Hours: 20:00
Enovis Research and Development Expense (Annual) : 120.33M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 120.33M |
| December 31, 2024 | 91.30M |
| December 31, 2023 | 75.33M |
| December 31, 2022 | 60.83M |
| December 31, 2021 | 49.09M |
| December 31, 2020 | 68.60M |
| December 31, 2019 | 61.80M |
| December 31, 2018 | 34.20M |
| December 31, 2017 | 42.90M |
| December 31, 2016 | 39.30M |
| December 31, 2015 | 41.50M |
| Date | Value |
|---|---|
| December 31, 2014 | 43.00M |
| December 31, 2013 | 27.40M |
| December 31, 2012 | 19.40M |
| December 31, 2011 | 5.707M |
| December 31, 2010 | 6.205M |
| December 31, 2009 | 5.93M |
| December 31, 2008 | 5.856M |
| December 31, 2007 | 4.162M |
| December 31, 2006 | 3.336M |
| December 31, 2005 | 2.855M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Intuitive Surgical, Inc. | 1.312B |
| STAAR Surgical Co. | 39.28M |
| Inspire Medical Systems, Inc. | 103.16M |
| Edwards Lifesciences Corp. | 1.079B |
| Kewaunee Scientific Corp. | 0.898M |